4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-007946
SVP & General Counsel sold 5,344 shares at $19.45 ($103,941)
- SVP & General Counsel acquired 5,344 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew SVP & General Counsel | 2021-02-03 | Option exercise | −5,344 | $8.80 | $47,027 | 84,244 | D: show line 1 in the form |
| Wilson Mark Andrew SVP & General Counsel | 2021-02-03 | Sale | −5,344 | $19.45 | $103,941 | 78,900 | D: show line 2 in the form |
| Open-market sales · 5,344 sh · avg $19.45 · $103,941 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew SVP & General Counsel | 2021-02-03 | Option exercise · Stock Option | −5,344 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…